February 26, 2026
GSK purchases 35Pharma for $950M to expand into pulmonary hypertension
GlaxoSmithKline has entered into an agreement to acquire Canadian clinical-stage biotech 35Pharma Inc. for $950 million in cash, expanding its respiratory and cardiovascular pipeline, according to regulatory filings and the company’s announcement.